Cargando…

One test to identify 50% of all Norwegian BRCA1 mutations

Detalles Bibliográficos
Autores principales:	Møller, P, Hovig, E, Lycke, K, Stacy, RAP, Dahlberg, OJ, Hagen, A, Hagen, B, Løvslett, K, Qvist, H, Heimdal, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300845/ http://dx.doi.org/10.1186/bcr147

Ejemplares similares

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations
por: Borg, Åke, et al.
Publicado: (1999)

Survival in Norwegian BRCA1 mutation carriers with breast cancer
por: Hagen, Anne Irene, et al.
Publicado: (2009)

Ten modifiers of BRCA1 penetrance validated in a Norwegian series
por: Heramb, Cecilie, et al.
Publicado: (2015)

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations
por: Reichelt, Jon G., et al.
Publicado: (1999)

Cerebral blood flow and oxidative metabolism during human endotoxaemia
por: Møller, K, et al.
Publicado: (2001)

The BRCA2 variant c.68-7 T>A is associated with breast cancer
por: Møller, Pål, et al.
Publicado: (2017)

Screening for germline rearrangements in BRCA1 and BRCA2 in Norwegian families with breast or breast/ovarian cancer
por: Van Ghelue, M, et al.
Publicado: (2005)

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer
por: Møller, Pål, et al.
Publicado: (2018)

Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality
por: Evans, D. G., et al.
Publicado: (2016)

Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000)

Selenium and the risk of cancer in BRCA1 carriers
por: Lubinski, J, et al.
Publicado: (2011)

Mycotoxins in Norwegian food and feed
por: Eriksen, Gunnar Sundstøl, et al.
Publicado: (2012)

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
por: Jaworska, K, et al.
Publicado: (2012)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

Vitamins A, E and D and cancer risk in BRCA1 carriers
por: Kąklewski, K, et al.
Publicado: (2012)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

A segregation analysis of testicular cancer based on Norwegian and Swedish families.
por: Heimdal, K., et al.
Publicado: (1997)

The contribution of LARGE genomic rearrangements of BRCA1 and BRCA2 gene mutations in breast and ovarian cancer families in a clinical cohort
por: Sawyer, S, et al.
Publicado: (2012)

Preliminary results of the new Norwegian cow index
por: Fimland, E
Publicado: (1982)

Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP
por: Kringen, P, et al.
Publicado: (2000)

BRCA2 interacting proteins
por: Vidarsson, H, et al.
Publicado: (2000)

BRCA1 testing in Lithuania
por: Janavicius, Ramunas
Publicado: (2012)

Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
por: Johnson, SM, et al.
Publicado: (2000)

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer
por: Martínez-Ferrandis, JI, et al.
Publicado: (2000)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2
por: Devilee, P
Publicado: (2001)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Searching for BRCA3 by exome sequencing
por: Makunin, I, et al.
Publicado: (2012)

Validation of the Norwegian Pain Sensitivity Questionnaire
por: Valeberg, Berit Taraldsen, et al.
Publicado: (2017)

Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation
por: Ertmański, S, et al.
Publicado: (2012)

BRCA1 mutation analysis in breast and ovarian cancer families from Greece
por: Konstantopoulou, I, et al.
Publicado: (2000)

A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival
por: Bolton, KL, et al.
Publicado: (2012)

Embryomanipulation – eine Biotechnik für Tierzüchter
por: Rottmann, OJ
Publicado: (1982)

Actual selection differences within herd for norwegian red cattle
por: Fimaland, E
Publicado: (1980)

The tech for the next decade: promises and challenges in genome biology
por: Hajirasouliha, Iman, et al.
Publicado: (2019)

Mammary-specific targeting of the murine BRCA2 breast cancer susceptibility gene in mice
por: Collins, NK, et al.
Publicado: (2000)

When, how and why BRCA1 and BRCA2 genetic testing is offered to patients who do not meet standard criteria
por: Duffy, J, et al.
Publicado: (2012)

EHMTI-0148. Perivascular spaces and headache: a population-based imaging study (MRI HUNT)
por: Husøy, AK, et al.
Publicado: (2014)

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift
por: Møller, Pål, et al.
Publicado: (2019)

BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial
por: Kote-Jarai, Z, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_c1dvu4vgqnf02qqg9b18jb1jgg